Searching for moonshot investment opportunities? These penny stocks have been highlighted by five-star Wall Street analysts as Buys, with the potential for significant gains from current price levels. Click on any ticker symbol to thoroughly research the stock before you decide whether to add it to your portfolio.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Quantum-Si (QSI) Stock – Quantum-Si is a biotechnology company focused on advancing the field of proteomics through its proprietary protein sequencing technology. Analyst Swayampakula Ramakanth from H.C. Wainwright reiterated his Buy rating on the stock while assigning a $4 price target. This equates to an upside of more than 222% from current levels.
Opus Genetics (IRD) Stock – Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company that focuses on developing and commercializing therapies for the treatment of patients with refractive and retinal eye disorders. Analyst Debanjana Chatterjee from JonesTrading reiterated her Buy rating on the stock and maintained a price target of $6 per share. This equates to an upside of more than 210% from current levels.
Dakota Gold Corp (DC) Stock – Dakota Gold engages in the acquisition and exploration of mineral properties. It primarily explores for gold deposits. Analyst Peter Bell from Canaccord Genuity reiterated his Buy rating on the stock while assigning a $14 per share price target. This equates to an upside of more than 256% from current levels.
To see the full list of recently rated stocks, visit TipRanks’ Daily Stock Ratings & Price Targets tool.